Sofie Isebaert

KU Leuven

Papers

2

Total Citations

37

H-Index

2

About

Dr. Sofie Isebaert is a leading clinical researcher in urologic oncology, with a primary focus on improving the staging and treatment strategies for prostate cancer. Her work bridges the gap between advanced imaging and clinical decision-making, most notably through her 2019 study on the "Impact of Magnetic Resonance Imaging on Prostate Cancer Staging and European Association of Urology Risk Classification." This highly cited paper (35 citations) demonstrated how integrating MRI significantly refines risk stratification, directly influencing treatment planning and surgical approaches. Dr. Isebaert has also made critical contributions to understanding patterns of postoperative care. Her 2020 population-based cohort study on adjuvant and early salvage radiotherapy after robot-assisted radical prostatectomy revealed that the availability of an on-site radiotherapy department at the surgical center is a strong, independent predictor of receiving postoperative radiation—highlighting systemic, non-clinical factors that drive treatment variation. This work underscores her commitment to optimizing real-world cancer care pathways. Through her research, Dr. Isebaert continues to shape evidence-based practices that improve outcomes for men with prostate cancer.

Research Focus

Key Achievements

2
H-Index
2
Papers
37
Total Citations
19
Avg Citations/Paper
🏆 Most Cited Paper
Impact of Magnetic Resonance Imaging on Prostate Cancer Staging and European Association of Urology Risk Classification
35 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: KU Leuven

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago